Jones RJ - Search Results

1

All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo.

Ma HS, Greenblatt SM, Shirley CM, Duffield AS, Bruner JK, Li L, Nguyen B, Jung E, Aplan PD, Ghiaur G, Jones RJ, Small D. Ma HS, et al. Among authors: jones rj. Blood. 2016 Jun 9;127(23):2867-78. doi: 10.1182/blood-2015-05-646786. Epub 2016 Apr 21. Blood. 2016. PMID: 27103744 Free PMC article.

2

Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalation.

Yeager AM, Wagner JE Jr, Graham ML, Jones RJ, Santos GW, Grochow LB. Yeager AM, et al. Among authors: jones rj. Blood. 1992 Nov 1;80(9):2425-8. Blood. 1992. PMID: 1421415 Free article.

3

Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.

Yeager AM, Vogelsang GB, Jones RJ, Farmer ER, Altomonte V, Hess AD, Santos GW. Yeager AM, et al. Among authors: jones rj. Blood. 1992 Jun 1;79(11):3031-5. Blood. 1992. PMID: 1586747 Free article.

4

Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation.

Miller CB, Zehnbauer BA, Piantadosi S, Rowley SD, Jones RJ. Miller CB, et al. Among authors: jones rj. Blood. 1991 Aug 15;78(4):1125-31. Blood. 1991. PMID: 1868244 Free article.

5

The action of bryostatin on normal human hematopoietic progenitors is mediated by accessory cell release of growth factors.

Sharkis SJ, Jones RJ, Bellis ML, Demetri GD, Griffin JD, Civin C, May WS. Sharkis SJ, et al. Among authors: jones rj. Blood. 1990 Aug 15;76(4):716-20. Blood. 1990. PMID: 2200537 Free article.

6

Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro.

Jones RJ, Sharkis SJ, Miller CB, Rowinsky EK, Burke PJ, May WS. Jones RJ, et al. Blood. 1990 Mar 15;75(6):1319-23. Blood. 1990. PMID: 2310830 Free article.

7

Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia.

Rowley SD, Jones RJ, Piantadosi S, Braine HG, Colvin OM, Davis J, Saral R, Sharkis S, Wingard J, Yeager AM, et al. Rowley SD, et al. Among authors: jones rj. Blood. 1989 Jul;74(1):501-6. Blood. 1989. PMID: 2665843 Free article.

8

Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantation.

Jones RJ, Zuehlsdorf M, Rowley SD, Hilton J, Santos GW, Sensenbrenner LL, Colvin OM. Jones RJ, et al. Blood. 1987 Nov;70(5):1490-4. Blood. 1987. PMID: 3311205 Free article.

9

BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents.

Bedi A, Barber JP, Bedi GC, el-Deiry WS, Sidransky D, Vala MS, Akhtar AJ, Hilton J, Jones RJ. Bedi A, et al. Among authors: jones rj. Blood. 1995 Aug 1;86(3):1148-58. Blood. 1995. PMID: 7620167 Free article.

10

Assessment of aldehyde dehydrogenase in viable cells.

Jones RJ, Barber JP, Vala MS, Collector MI, Kaufmann SH, Ludeman SM, Colvin OM, Hilton J. Jones RJ, et al. Blood. 1995 May 15;85(10):2742-6. Blood. 1995. PMID: 7742535 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

761 results

Search Page

Filters